SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-23-000113
Filing Date
2023-05-10
Accepted
2023-05-10 07:06:26
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20230331.htm   iXBRL 10-Q 1494921
2 EX-10.1 ex101-zntlxformofindemnifi.htm EX-10.1 120180
3 EX-10.2 ex102-zntlxsublease_zental.htm EX-10.2 139013
4 EX-31.1 zentalis10-qq12023ex311.htm EX-31.1 10841
5 EX-31.2 zentalis10-qq12023ex312.htm EX-31.2 11060
6 EX-32.1 zentalis10-qq12023ex321.htm EX-32.1 5688
7 EX-32.2 zentalis10-qq12023ex322.htm EX-32.2 5269
13 zntl-20230331_g1.jpg GRAPHIC 180516
  Complete submission text file 0001725160-23-000113.txt   6463594

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20230331.xsd EX-101.SCH 32916
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20230331_cal.xml EX-101.CAL 69879
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20230331_def.xml EX-101.DEF 136119
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20230331_lab.xml EX-101.LAB 430158
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20230331_pre.xml EX-101.PRE 287569
64 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20230331_htm.xml XML 808086
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 23904295
SIC: 2834 Pharmaceutical Preparations